[1]
|
应振华, 张园, 王小冬. 《2020中国系统性红斑狼疮诊疗指南》解读[J]. 浙江医学, 2022, 44(1): 1-5.
|
[2]
|
Charras, A., Smith, E. and Hedrich, C. (2021) Systemic Lupus Erythematosus in Children and Young People. Systemic Lupus Er-ythematosus, 23, Article No. 20. https://doi.org/10.1007/s11926-021-00985-0
|
[3]
|
Vincze, K., Odler, B. and Mül-ler, V. (2016) Pulmonary Manifestations in Systemic Lupus Erythematosus. Orvosi Hetilap, 157, 1154-1160. https://doi.org/10.1556/650.2016.30482
|
[4]
|
Aguilera-Pickens, G. and Abud-Mendoza, C. (2018) Pulmonary Manifestations in Systemic Lupus Erythematosus: Pleural Involvement, Acute Pneumonitis, Chronic Interstitial Lung Disease and Diffuse Alveolar Hemorrhage. Reumatologia Clinica, 14, 294-300. https://doi.org/10.1016/j.reuma.2018.03.012
|
[5]
|
Wallace, D.J., Salonen, E.M., Avaniss-Aghajani, E., et al. (2000) Anti-Telomere Antibodies in Systemic Lupus Erythematosus: A New ELISA Test for Anti-DNA with Potential Patho-genetic Implications. Lupus, 9, 328-332.
https://doi.org/10.1191/096120300678828343
|
[6]
|
Delgado, E.A., Malleson, P.N., Pirie, G.E., et al. (1990) The Pulmonary Manifestations of Childhood Onset Systemic Lupus Erythematosus. Seminars in Arthritis and Rheumatism, 19, 285-293.
https://doi.org/10.1016/0049-0172(90)90051-G
|
[7]
|
Yeh, T.T., Yang, Y.H., Lin, Y.T., et al. (2007) Cardiopulmo-nary Involvement in Pediatric Systemic Lupus Erythematosus: A Twenty-Year Retrospective Analysis. Journal of Mi-crobiology, Immunology, and Infection, 40, 525-531.
|
[8]
|
赵燕凤, 卢美萍, 陈志敏. 儿童系统性红斑狼疮伴肺胸膜病变的临床特征分析[J]. 浙江大学学报(医学版), 2012, 41(3): 327-331.
|
[9]
|
Antoniou, K.M., Margaritopoulos, G., Economidou, F., et al. (2009) Pivotal Clinical Dilemmas in Collagen Vascular Diseases Associated with Interstitial Lung Involvement. The European Respiratory Journal, 33, 882-896.
https://doi.org/10.1183/09031936.00152607
|
[10]
|
Guo, H., Leung, J.C., Chan, L.Y., et al. (2004) The Pathogenetic Role of Immunoglobulin G from Patients with Systemic Lupus Erythematosus in the Development of Lupus Pleuritis. Rheumatology (Oxford), 43, 286-293.
https://doi.org/10.1093/rheumatology/keh054
|
[11]
|
Caccavo, D., Afeltra, A., Rigon, A., et al. (2008) Antibodies to Carbonic Anhydrase in Patients with Connective Tissue Diseases: Relationship with Lung Involvement. International Journal of Immunopathology and Pharmacology, 21, 659-667. https://doi.org/10.1177/039463200802100320
|
[12]
|
Torre, O. and Harari, S. (2011) Pleural and Pulmonary In-volvement in Systemic Lupus Erythematosus. La Presse Médicale, 40, e19-e29. https://doi.org/10.1016/j.lpm.2010.11.004
|
[13]
|
Mira-Avendano, I.C. and Abril, A. (2015) Pulmonary Manifesta-tions of Sjögren Syndrome, Systemic Lupus Erythematosus, and Mixed Connective Tissue Disease. Rheumatic Diseases Clinics of North America, 41, 263-277.
https://doi.org/10.1016/j.rdc.2015.01.001
|
[14]
|
Winslow, W.A., Ploss, L.N. and Loitman, B. (1958) Pleuritis in Systemic Lupus Erythematosus: Its Importance as an Early Manifestation in Diagnosis. Annals of Internal Medicine, 49, 70-88. https://doi.org/10.7326/0003-4819-49-1-70
|
[15]
|
Glazer, M., Berkman, N., Lafair, J.S., et al. (2000) Suc-cessful Talc Slurry Pleurodesis in Patients with Nonmalignant Pleural Effusion. Chest, 117, 1404-1409. https://doi.org/10.1378/chest.117.5.1404
|
[16]
|
吴雪, 罗采南, 石亚妹, 等. KL-6在结缔组织病合并间质性肺病诊断中的应用价值[J]. 中国免疫学杂志, 2018, 34(11): 1716-1719.
|
[17]
|
马洁, 王婷, 戴鸽, 等. 儿童系统性红斑狼疮伴间质性肺疾病的临床特征及危险因素分析[J]. 中华实用儿科临床杂志, 2022, 37(1): 16-20.
|
[18]
|
陈晓芳, 杨敏, 赵进军, 等. 系统性红斑狼疮合并间质性肺炎的临床特征及相关危险因素分析[J]. 重庆医学, 2018, 47(11): 1460-1464.
|
[19]
|
Hime, N.J., Zurynski, Y., Fitzgerald, D., et al. (2015) Childhood Interstitial Lung Disease: A System-atic Review. Pediatric Pulmonology, 50, 1383-1392. https://doi.org/10.1002/ppul.23183
|
[20]
|
张金涛, 戴冰冰, 刘畅, 等. 类风湿关节炎合并间质性肺病中肿瘤标志物的意义[J]. 中国现代医药杂志, 2018, 20(5): 22-25.
|
[21]
|
Csernok, E. (2019) The Diagnostic and Clinical Utility of Autoantibodies in Systemic Vasculitis. Antibodies (Basel, Switzerland), 8, Article No. 31. https://doi.org/10.3390/antib8020031
|
[22]
|
Li, S.S., Wang, S.L., Zhang, H.J., et al. (2020) The Pathogenesis and Treatment in Antineutrophil Cytoplasmic Antibody Associated Vasculitis. American Journal of Translational Research, 12, 4094-4107.
|
[23]
|
Wang, Z., Chang, C., Peng, M., et al. (2017) Trans-lating Epigenetics into Clinic: Focus on Lupus. Clinical Epigenetics, 9, Article No. 78. https://doi.org/10.1186/s13148-017-0378-7
|
[24]
|
Mizus, M., Li, J., Goldman, D., et al. (2019) Autoantibody Clus-tering of Lupus-Associated Pulmonary Hypertension. Lupus Science & Medicine, 6, e000356. https://doi.org/10.1136/lupus-2019-000356
|
[25]
|
王金华, 查旭山. 系统性红斑狼疮并发间质性肺病危险因素及中医证型相关性分析[J]. 广州中医药大学学报, 2022, 39(11): 2476-2482.
|
[26]
|
Memet, B. and Ginzler, E.M. (2007) Pulmonary Manifestations of Systemic Lupus Erythematosus. Seminars in Respiratory and Critical Care Medi-cine, 28, 441-450. https://doi.org/10.1055/s-2007-985665
|
[27]
|
Araujo, D.B., Borba, E.F., Silva, C.A., et al. (2012) Alveolar Hemorrhage: Distinct Features of Juvenile and Adult Onset Systemic Lupus Erythematosus. Lupus, 21, 872-877. https://doi.org/10.1177/0961203312441047
|
[28]
|
Segal, A.M., Calabrese, L.H., Ahmad, M., et al. (1985) The Pulmonary Manifestations of Systemic Lupus Erythematosus. Seminars in Arthritis and Rheumatism, 14, 202-224. https://doi.org/10.1016/0049-0172(85)90040-X
|
[29]
|
García-Guevara, G., Ríos-Corzo, R., Díaz-Mora, A., et al. (2018) Pneumonia in Patients with Systemic Lupus Erythematosus: Epidemiology, Microbiology and Outcomes. Lupus, 27, 1953-1959.
https://doi.org/10.1177/0961203318799207
|
[30]
|
Amarnani, R., Yeoh, S.A., Denneny, E.K., et al. (2020) Lupus and the Lungs: The Assessment and Management of Pulmonary Manifestations of Systemic Lupus Erythematosus. Frontiers in Medicine, 7, Article ID: 610257.
https://doi.org/10.3389/fmed.2020.610257
|
[31]
|
Swigris, J.J., Fischer, A., Gillis, J., et al. (2008) Pulmonary and Thrombotic Manifestations of Systemic Lupus Erythematosus. Chest, 133, 271-280. https://doi.org/10.1378/chest.07-0079
|
[32]
|
Cantero, C., Vongthilath, R. and Plojoux, J. (2020) Acute Lupus Pneumonitis as the Initial Presentation of Systemic Lupus Erythematosus. BMJ Case Reports, 13, e234638. https://doi.org/10.1136/bcr-2020-234638
|
[33]
|
Fanouriakis, A., Tziolos, N., Bertsias, G., et al. (2021) Update on the Diagnosis and Management of Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 80, 14-25. https://doi.org/10.1136/annrheumdis-2020-218272
|
[34]
|
Kinder, B.W., Freemer, M.M., King, T.E., et al. (2007) Clinical and Genetic Risk Factors for Pneumonia in Systemic Lupus Erythematosus. Arthritis & Rheumatology, 56, 2679-2686. https://doi.org/10.1002/art.22804
|
[35]
|
Gladman, D.D., Hussain, F., Ibañez, D., et al. (2002) The Na-ture and Outcome of Infection in Systemic Lupus Erythematosus. Lupus, 11, 234-239. https://doi.org/10.1191/0961203302lu170oa
|
[36]
|
The, C.L., Wan, S.A. and Ling, G.R. (2018) Severe Infections in Systemic Lupus Erythematosus: Disease Pattern and Predictors of Infection-Related Mortality. Clinical Rheumatology, 37, 2081-2086.
https://doi.org/10.1007/s10067-018-4102-6
|
[37]
|
Feldman, C.H., Marty, F.M., Winkelmayer, W.C., et al. (2017) Comparative Rates of Serious Infections among Patients with Systemic Lupus Erythematosus Receiving Immunosup-pressive Medications. Arthritis & Rheumatology (Hoboken, NJ), 69, 387-397. https://doi.org/10.1002/art.39849
|
[38]
|
Yang, Y., Jiang, H., Wang, C., et al. (2021) Clinical Characteristics and Prognoses of Patients with Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections. Frontiers in Medicine, 8, Article ID: 732681.
https://doi.org/10.3389/fmed.2021.732681
|
[39]
|
Di Bartolomeo, S., Alunno, A. and Carubbi, F. (2021) Respiratory Manifestations in Systemic Lupus Erythematosus. Pharmaceuticals (Basel, Switzerland), 14, Article No. 276. https://doi.org/10.3390/ph14030276
|
[40]
|
吴满辉, 林小鸿, 吴海东. 血清降钙素原在早期诊断系统性红斑狼疮合并肺部感染中的应用[J]. 岭南急诊医学杂志, 2019, 24(5): 452-453, 466.
|
[41]
|
Dell’era, L., Corona, F., Defilippi, A.C., et al. (2012) Systemic Lupus Erythematosus Presenting with Pulmonary Thromboembolism in a 15-Year-Old Girl. Rheumatology International, 32, 2925-2928.
https://doi.org/10.1007/s00296-010-1483-5
|
[42]
|
Mok, C.C., Ho, L.Y., Yu, K.L., et al. (2010) Venous Thrombo-embolism in Southern Chinese Patients with Systemic Lupus Erythematosus. Clinical Rheumatology, 29, 599-604. https://doi.org/10.1007/s10067-009-1364-z
|
[43]
|
Brouwer, J.L., Bijl, M., Veeger, N.J., et al. (2004) The Contribu-tion of Inherited and Acquired Thrombophilic Defects, Alone or Combined with Antiphospholipid Antibodies, to Venous and Arterial Thromboembolism in Patients with Systemic Lupus Erythematosus. Blood, 104, 143-148. https://doi.org/10.1182/blood-2003-11-4085
|
[44]
|
Kumar, A., Ghazanfar, H. and Altaf, F. (2021) Systemic Lupus Erythematosus Presenting as Pulmonary Embolism after Liposuction: A Clinical Conundrum. Cureus, 13, e16076. https://doi.org/10.7759/cureus.16076
|
[45]
|
Jiménez-Zarazúa, O., Vélez-Ramírez, L.N., Ramírez-Casillas, C.A., et al. (2022) Pulmonary Thromboembolism and Alveolar Hemorrhage as Initial Manifestations of Systemic Lupus Erythema-tosus. Lupus, 31, 116-124.
https://doi.org/10.1177/09612033211066481
|
[46]
|
Bhat, M.A., Qureshi, U.A., Ali, S.W., et al. (2011) Pulmonary Thromboembolism as the Initial Manifestation in a Child with Antiphospholipid Syndrome in the Emergency Department. Pediatric Emergency Care, 27, 205-207.
https://doi.org/10.1097/PEC.0b013e31820d8dd4
|
[47]
|
Harroche, A., Remus, N., Gaubicher, S., et al. (2009) Pul-monary Thrombosis as the First Manifestation of Systemic Lupus Erythematosus in a 14-Year-Old Boy. Pediatric Nephrology (Berlin, Germany), 24, 857-861.
https://doi.org/10.1007/s00467-008-1037-1
|
[48]
|
Zhao, Y., Huang, C., You, H., et al. (2022) Prognostic Factors of Systemic Lupus Erythematosus Patients with Pulmonary Embolism: An 11-Year Cohort Study. Lupus, 31, 885-890. https://doi.org/10.1177/09612033221095149
|
[49]
|
Uehara, M., Matsushita, S., Aochi, S., et al. (2023) Positive An-tiphospholipid Antibodies and Pulmonary Embolism in a Patient with Adalimumab-Induced Lupus. Modern Rheumatol-ogy Case Reports, 7, 68-73.
https://doi.org/10.1093/mrcr/rxac074
|
[50]
|
Prabu, A., Patel, K., Yee, C.S., et al. (2009) Prevalence and Risk Factors for Pulmonary Arterial Hypertension in Patients with Lupus. Rheumatology (Oxford), 48, 1506-1511. https://doi.org/10.1093/rheumatology/kep203
|
[51]
|
Anuardo, P., Verdier, M., Gormezano, N.W., et al. (2017) Sub-clinical Pulmonary Hypertension in Childhood Systemic Lupus Erythematosus Associated with Minor Disease Manifes-tations. Pediatric Cardiology, 38, 234-239.
https://doi.org/10.1007/s00246-016-1504-6
|
[52]
|
Schreiber, B.E., Connolly, M.J. and Coghlan, J.G. (2013) Pul-monary Hypertension in Systemic Lupus Erythematosus. Best Practice & Research Clinical Rheumatology, 27, 425-434. https://doi.org/10.1016/j.berh.2013.07.011
|
[53]
|
Torres Jimenez, A.R., Ruiz Vela, N., Cespedes Cruz, A.I., et al. (2021) Shrinking Lung Syndrome in Pediatric Systemic Lupus Erythematosus. Lupus, 30, 1175-1179. https://doi.org/10.1177/09612033211010331
|
[54]
|
Toya, S.P. and Tzelepis, G.E. (2009) Association of the Shrink-ing Lung Syndrome in Systemic Lupus Erythematosus with Pleurisy: A Systematic Review. Seminars in Arthritis and Rheumatism, 39, 30-37.
https://doi.org/10.1016/j.semarthrit.2008.04.003
|
[55]
|
Borrell, H., Narváez, J., Alegre, J.J., et al. (2016) Shrinking Lung Syndrome in Systemic Lupus Erythematosus: A Case Series and Review of the Literature. Medicine (Baltimore), 95, e4626.
https://doi.org/10.1097/MD.0000000000004626
|
[56]
|
Satiş, H., Cindil, E., Salman, R.B., et al. (2020) Diaphrag-matic Muscle Thickness and Diaphragmatic Function Are Reduced in Patients with Systemic Lupus Erythematosus Compared to Those with Primary Sjögren’s Syndrome. Lupus, 29, 715-720. https://doi.org/10.1177/0961203320919848
|